Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 13/20 | 0.36 |
| ▸ | ADRB1 | P08588 | 13/20 | 0.36 |
| ▸ | ADRB3 | P13945 | 13/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19651555 | 0.89 | SMN1; SMN2 (0.38) | ADRB2ADRB1ADRB3 | |
| SCHEMBL19355186 | 0.80 | SMN1; SMN2 (0.46) | — | |
| SCHEMBL19651556 | 0.80 | SMN1; SMN2 (0.39) | ADRB2ADRB1ADRB3 | |
| SCHEMBL19355185 | 0.74 | CYP2D6 (0.42) | ADRB2ADRB1ADRB3 | |
| SCHEMBL19656624 | 0.72 | KDM4E (0.36) | ADRB2ADRB1ADRB3 | |
| SCHEMBL17793973 | 0.72 | SMN1; SMN2 (0.34) | — | |
| SCHEMBL21674072 | 0.71 | CHRNB2 (0.44) | — | |
| SCHEMBL19656717 | 0.71 | TSHR (0.38) | — | |
| SCHEMBL8533788 | 0.70 | CYP3A4 (0.51) | — | |
| SCHEMBL6141476 | 0.70 | LMNA (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170342046-A1 | Fatty Acid Cysteine-Based Conjugates and Their Use in Treating Medical Disorders | CATABASIS PHARMACEUTICALS, INC. | 2017-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170342046-A1 | Fatty Acid Cysteine-Based Conjugates and Their Use in Treating Medical Disorders | CPT2, FABP1, ACAA2 | ADRB2 3196/4885ADRB1 2719/4885ADRB3 2035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.